Certified CME provider: Excerpta Medica

Company Profile
Excerpta Medica Inc., an Elsevier business, is a global medical communications company headquartered in the US and The Netherlands. Since 1946, Excerpta Medica (www.excerptamedica.com) has been partnering with its clients in the pharmaceutical and biotech industries to ensure healthcare professionals will have the information they need to make informed decisions regarding treatment options for their patients. As part of Elsevier, the world's largest medical and scientific publisher, Excerpta Medica leverages Elsevier's many resources to build unique and powerful medical communications solutions.

Services and Offerings
The team of professionals at Excerpta Medica think, create and deliver a full line of strategic solutions in the areas of:

Strategic Publications Planning
Excerpta Medica develops and implements strategic publications plans, and provides expertise in scientific writing, abstracts and poster development for scientific congresses, and gap and competitor analysis.

Medical Education
We deliver a range of strategic, scientific and creative communications solutions including satellite symposia, teleconferences, advisory board meetings, investigator training meetings, slide kits, KOL development programs and e-media.

Custom and Medical Publishing
With a variety of publication solutions ranging from rapid, peer-reviewed titles such as Clinical Therapeutics and The American Journal of Geriatric Pharmacotherapy, to industry-sponsored publications like Clinical Cornerstone, we leverage Elsevier's well-known book and journal titles to create customized solutions based on specific client and target audience needs.

Interactive Solutions
Our award-winning team at Excerpta Medica Interactive creates and implements innovative online medical communications solutions that successfully drive clients' educational strategies. We achieve our clients' goals by creating innovative, intuitive and interactive solutions for the world's leading healthcare brands.
You must be a registered member of MMM to post a comment.

Email Newsletters


What does going "beyond the pill" actually mean? At MM&M's recent inaugural spring conference, audience members heard from real-world companies that are managing the organizational, technological, and promotional challenges inherent in this transition, such as partnering with health neophytes, harnessing technologies that allow deeper engagement with patients, and adopting a new commercial mindset to serve, not sell. Download here.


A wave of more effective anti-cancer drugs has set the oncology world on fire with enthusiasm. While many hail this as a new era, an equally vocal faction questions the money spent for the value gained. This medical and commercial trend report for marketers of anti-cancer modalities touches on many of the latest shifts that have expedited product launches and otherwise impacted promotion and reimbursement of these drugs. Click here.